CoChat

Biomarkers in Substance Use Disorders

Volkow, Nora D, Koob, George, Baler, Ruben · 2015 · ACS Chemical Neuroscience

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

The prevention and treatment of substance use disorders (SUDs), including addiction, would benefit from having better biomarkers for the classification of patients into categories that are reproducible and have predictive validity. Direct measurement of drugs or their metabolites in various body fluids constitutes a clinically valuable biomarker but one that can only be used to corroborate acute or relatively recent drug use. Thus, there is an urgent need for biomarkers that reflect chronic drug exposure as well as biomarkers that predict or correlate with disease trajectories and treatment responses. Advances in tools and technologies to investigate genetics, epigenetics and epitranscriptomics, and human brain function and neurochemistry (brain imaging tools including EEG) offer unprecedented opportunities for the development of such biomarkers. Progress in this area will not only enhance our ability to screen and treat patients with SUDs but also accelerate research on the neurobiological processes that underlie SUDs.

Overview

Integrity signals

Registry

Crossref · 10.1021/acschemneuro.5b00067

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 41 references

Research works printed but not linked: 1

  1. Edenberg H. J., 2007, Alcohol Res. Health, 30, 5

Cited by

See all 145

Metadata

Authors
Volkow, N. D., Koob, G., & Baler, R.
Affiliations
  • National Institutes of Health (US)
  • National Institute on Drug Abuse and ‡National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20892, United States
Corresponding author
Volkow, Nora D
Venue
ACS Chemical Neuroscience
Published
2015-03-18
Volume
6
Issue
4
Pages
522-525
ISSN
1948-7193 (ISSN-L)
OpenAlex
W2057763983
Cited by
141
References
41
Citations by year
2026: 5 · 2025: 14 · 2024: 17 · 2023: 8 · 2022: 18 · 2021: 13 · 2020: 11 · 2019: 13 · 2018: 15 · 2017: 10 · 2016: 13 · 2015: 4
FWCI
1.82
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Chemical Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
substance use disorders, addiction, biomarkers, chronic drug exposure, disease trajectories, treatment response prediction, epigenetics, epitranscriptomics, neuroimaging, EEG, neurochemistry
MeSH terms
Animals, Humans, Biomarkers, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biomarkers in Substance Use Disorders. https://app.cochat.ai/papers/10.1021/acschemneuro.5b00067
The paper
Volkow, N. D., Koob, G., & Baler, R. (2015). Biomarkers in Substance Use Disorders. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5b00067

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.